Purdue Pharma has sought to delay a trial that is set to begin May 28 in Oklahoma, citing a “belated tidal wave of documents,” but the move comes amid reports that the opioid manufacturer could soon file for Chapter 11 bankruptcy.
In a case brought by the Oklahoma attorney general, the trial would be the first time a jury would decide whether Purdue was responsible for the opioid addiction crisis. Last week, Purdue filed a motion for continuance based on a massive data dump handed over by the attorney general’s office. On Friday, Attorney General Mike Hunter countered that Purdue’s motion was a ruse that, along with a potential bankruptcy filing, were all part of a “desperate” attempt to avoid trial.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]